GLP-1 agonists (semaglutide, tirzepatide, liraglutide) are NOT controlled substances and can generally be prescribed via telehealth in all states, as long as you establish a proper patient-provider relationship and meet standard of care
Protects organs under oxidative stress (e.g., liver, heart, brain)
Increased lipophilicity of the drug may lead to enhanced plasma protein binding resulting in a diminished unbound plasma concentration of the drug (28)
Insurance does not cover this service but we offer packages to make this therapy more affordable
The eMC SmPC for orlistat (Xenical/Alli) advises that the two medicines should be separated by at least 4 hours, and that thyroid function should be monitored after orlistat is initiated typically at around 68 weeks with levothyroxine dose adjustment as required
Compounding pharmacies are allowed to produce non-identical versions of GLP-1 drugs, such as semaglutide and liraglutide, under specific FDA regulations , especially during times of shortage